Dalpiciclib With or Without Entinostat and Letrozole in HR+/HER2- Early Breast Cancer
Clinical trial NCT07492394 · RECRUITING
Trial details
- NCT number
- NCT07492394
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-12
- Primary completion
- 2026-12-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.